91 related articles for article (PubMed ID: 11295049)
1. Selective growth inhibition by sangivamycin of human umbilical vein endothelial cells.
Ohno O; Shima Y; Ikeda Y; Kondo SI; Kato K; Toi M; Umezawa K
Int J Oncol; 2001 May; 18(5):1009-15. PubMed ID: 11295049
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, cytotoxicity, and antiviral activity of some acyclic analogues of the pyrrolo[2,3-d]pyrimidine nucleoside antibiotics tubercidin, toyocamycin, and sangivamycin.
Gupta PK; Daunert S; Nassiri MR; Wotring LL; Drach JC; Townsend LB
J Med Chem; 1989 Feb; 32(2):402-8. PubMed ID: 2913300
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tumor angiogenesis by targeting endothelial surface ATP synthase with sangivamycin.
Komi Y; Ohno O; Suzuki Y; Shimamura M; Shimokado K; Umezawa K; Kojima S
Jpn J Clin Oncol; 2007 Nov; 37(11):867-73. PubMed ID: 17956898
[TBL] [Abstract][Full Text] [Related]
4. Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cells.
Kumeda SI; Deguchi A; Toi M; Omura S; Umezawa K
Anticancer Res; 1999; 19(5B):3961-8. PubMed ID: 10628338
[TBL] [Abstract][Full Text] [Related]
5. A new biological role of sangivamycin; inhibition of protein kinases.
Osada H; Sonoda T; Tsunoda K; Isono K
J Antibiot (Tokyo); 1989 Jan; 42(1):102-6. PubMed ID: 2921215
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of angiogenic tubule formation and induction of apoptosis in human endothelial cells by the selective cyclooxygenase-2 inhibitor 5-bromo-2-(4-fluorophenyl)-3-(methylsulfonyl) thiophene (DuP-697).
Churchman A; Baydoun AR; Hoffman R
Eur J Pharmacol; 2007 Nov; 573(1-3):176-83. PubMed ID: 17643408
[TBL] [Abstract][Full Text] [Related]
7. ARC (NSC 188491) has identical activity to Sangivamycin (NSC 65346) including inhibition of both P-TEFb and PKC.
Stockwin LH; Yu SX; Stotler H; Hollingshead MG; Newton DL
BMC Cancer; 2009 Feb; 9():63. PubMed ID: 19232100
[TBL] [Abstract][Full Text] [Related]
8. Nucleic acid related compounds. 51. Synthesis and biological properties of sugar-modified analogues of the nucleoside antibiotics tubercidin, toyocamycin, sangivamycin, and formycin.
De Clercq E; Balzarini J; Madej D; Hansske F; Robins MJ
J Med Chem; 1987 Mar; 30(3):481-6. PubMed ID: 3820218
[TBL] [Abstract][Full Text] [Related]
9. Cytokinetic and biochemical effects of sangivamycin in human colon carcinoma cells in culture.
Glazer RI; Hartman KD
Mol Pharmacol; 1981 Nov; 20(3):657-61. PubMed ID: 7329408
[No Abstract] [Full Text] [Related]
10. Characterization of gastrin-induced proangiogenic effects in vivo in orthotopic U373 experimental human glioblastomas and in vitro in human umbilical vein endothelial cells.
Lefranc F; Mijatovic T; Mathieu V; Rorive S; Decaestecker C; Debeir O; Brotchi J; Van Ham P; Salmon I; Kiss R
Clin Cancer Res; 2004 Dec; 10(24):8250-65. PubMed ID: 15623601
[TBL] [Abstract][Full Text] [Related]
11. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of methylmercury on migration and tube formation by cultured human vascular endothelial cells.
Kishimoto T; Oguri T; Abe M; Kajitani H; Tada M
Arch Toxicol; 1995; 69(6):357-61. PubMed ID: 7495372
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the cellular and RNA-dependent effects of sangivamycin and toyocamycin in human colon carcinoma cells.
Cohen MB; Glazer RI
Mol Pharmacol; 1985 Mar; 27(3):349-55. PubMed ID: 2579317
[TBL] [Abstract][Full Text] [Related]
14. Sangivamycin induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells.
Wakao K; Watanabe T; Takadama T; Ui S; Shigemi Z; Kagawa H; Higashi C; Ohga R; Taira T; Fujimuro M
Biochem Biophys Res Commun; 2014 Feb; 444(2):135-40. PubMed ID: 24434142
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and ++thiosangivamycin: influence of various 7-substituents on antiviral activity.
Renau TE; Wotring LL; Drach JC; Townsend LB
J Med Chem; 1996 Feb; 39(4):873-80. PubMed ID: 8632411
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic effect of KR-31372 by apoptosis via mediation of mitochondrial KATP channel opening and the phosphatase and tensin homolog deleted from chromosome 10 phosphorylation.
Kim KY; Shin YW; Kim SO; Lim H; Yoo SE; Hong KW
J Pharmacol Exp Ther; 2003 Jun; 305(3):1142-9. PubMed ID: 12626642
[TBL] [Abstract][Full Text] [Related]
17. Sangivamycin and its derivatives inhibit Haspin-Histone H3-survivin signaling and induce pancreatic cancer cell death.
Bastea LI; Hollant LMA; Döppler HR; Reid EM; Storz P
Sci Rep; 2019 Nov; 9(1):16588. PubMed ID: 31719634
[TBL] [Abstract][Full Text] [Related]
18. Cytostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470).
Kusaka M; Sudo K; Matsutani E; Kozai Y; Marui S; Fujita T; Ingber D; Folkman J
Br J Cancer; 1994 Feb; 69(2):212-6. PubMed ID: 8297716
[TBL] [Abstract][Full Text] [Related]
19. Levamisole induced apoptosis in cultured vascular endothelial cells.
Artwohl M; Hölzenbein T; Wagner L; Freudenthaler A; Waldhäusl W; Baumgartner-Parzer SM
Br J Pharmacol; 2000 Dec; 131(8):1577-83. PubMed ID: 11139434
[TBL] [Abstract][Full Text] [Related]
20. Transmigration of human ovarian adenocarcinoma cells through endothelial extracellular matrix involves alphav integrins and the participation of MMP2.
Leroy-Dudal J; Demeilliers C; Gallet O; Pauthe E; Dutoit S; Agniel R; Gauduchon P; Carreiras F
Int J Cancer; 2005 Apr; 114(4):531-43. PubMed ID: 15609323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
